RBC Capital analyst Brian Abrahams says shares of Sarepta (SRPT) could be trading lower today on an FDA database update that ...

Nisa Investment Advisors LLC grew its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 23.1% ...

The firm will share new overall survival data from the INAVO120 trial with regulators to support the breast cancer drug's approval.

My vote for the best credit card offer of February 2025 goes to my favorite hotel card: the IHG One Rewards Premier Credit ...

The U.S. Food and Drug Administration (FDA) recently issued two new guidance documents governing details of the Accelerated Approval ...